Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,120 | 13 | 97.0% |
| Education | $34.95 | 1 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $633.50 | 7 | $0 (2023) |
| Novo Nordisk Inc | $350.57 | 4 | $0 (2024) |
| Corcept Therapeutics | $75.26 | 1 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $61.03 | 1 | $0 (2021) |
| PFIZER INC. | $34.95 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $192.08 | 3 | Novo Nordisk Inc ($116.82) |
| 2023 | $573.85 | 6 | Amgen Inc. ($340.10) |
| 2022 | $125.00 | 1 | Amgen Inc. ($125.00) |
| 2021 | $61.03 | 1 | Regeneron Pharmaceuticals, Inc. ($61.03) |
| 2020 | $101.62 | 2 | Amgen Inc. ($66.67) |
| 2019 | $101.73 | 1 | Amgen Inc. ($101.73) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $60.67 | General |
| 10/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $75.26 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $56.15 | General |
| 11/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $130.91 | General |
| Category: Obesity | ||||||
| 11/09/2023 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 07/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $102.84 | General |
| 02/13/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $71.70 | General |
| Category: Cardiology | ||||||
| 02/13/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $71.70 | General |
| Category: Cardiology | ||||||
| 02/13/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $71.70 | General |
| Category: Cardiology | ||||||
| 04/27/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 12/08/2021 | Regeneron Pharmaceuticals, Inc. | PRALUENT (Biological), EVKEEZA | Food and Beverage | In-kind items and services | $61.03 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 09/16/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $66.67 | General |
| Category: Cardiology | ||||||
| 09/14/2020 | PFIZER INC. | EUCRISA (Drug) | Education | In-kind items and services | $34.95 | General |
| Category: DERMATOLOGY | ||||||
| 02/06/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $101.73 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 4,747 | 6,547 | $860,812 | $254,655 |
| 2022 | 54 | 5,654 | 7,635 | $933,712 | $269,657 |
| 2021 | 53 | 6,300 | 8,315 | $997,644 | $291,960 |
| 2020 | 46 | 5,864 | 7,497 | $959,524 | $246,725 |
All Medicare Procedures & Services
199 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 589 | 1,206 | $423,306 | $100,510 | 23.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 458 | 458 | $172,208 | $58,052 | 33.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 477 | 750 | $25,500 | $9,801 | 38.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 42 | 44 | $32,824 | $9,529 | 29.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $18,046 | $7,853 | 43.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 514 | 1,004 | $14,963 | $7,405 | 49.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 60 | $28,200 | $7,346 | 26.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 98 | 98 | $15,484 | $7,039 | 45.5% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 34 | 34 | $11,186 | $4,862 | 43.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 426 | 466 | $12,582 | $4,817 | 38.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 166 | 229 | $9,847 | $3,758 | 38.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 422 | 487 | $9,740 | $3,702 | 38.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 87 | 106 | $7,950 | $3,075 | 38.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 101 | 101 | $6,666 | $3,053 | 45.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 190 | 294 | $7,350 | $2,770 | 37.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $9,146 | $2,596 | 28.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $8,464 | $2,558 | 30.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 96 | 96 | $4,416 | $1,816 | 41.1% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 38 | 41 | $4,264 | $1,658 | 38.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 101 | 106 | $4,028 | $1,567 | 38.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 34 | 34 | $3,400 | $1,371 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 27 | $6,453 | $1,259 | 19.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $2,077 | $937.13 | 45.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 83 | 106 | $2,332 | $872.91 | 37.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 16 | $2,752 | $654.56 | 23.8% |
About Dr. Michael Harris, M.D
Dr. Michael Harris, M.D is a Internal Medicine healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023047503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Harris, M.D has received a total of $1,155 in payments from pharmaceutical and medical device companies, with $192.08 received in 2024. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($1,120).
As a Medicare-enrolled provider, Harris has provided services to 22,565 Medicare beneficiaries, totaling 29,994 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 199 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bend, OR
- Active Since 06/30/2006
- Last Updated 03/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1023047503
Products in Payments
- Repatha (Biological) $508.50
- Wegovy (Drug) $130.91
- Korlym (Drug) $75.26
- PRALUENT (Biological) $61.03
- EUCRISA (Drug) $34.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bend
Dr. Mary Carroll, M.d, M.D
Internal Medicine — Payments: $74,687
Bruce Mclellan, M.d, M.D
Internal Medicine — Payments: $19,127
Manish Mehta, Md, MD
Internal Medicine — Payments: $16,763
Erinn Hughes, M.d, M.D
Internal Medicine — Payments: $13,420
Nicholas Buss
Internal Medicine — Payments: $6,759
Michael Widmer, M.d, M.D
Internal Medicine — Payments: $5,824